STOCK TITAN

Inotiv Inc Stock Price, News & Analysis

NOTV Nasdaq

Welcome to our dedicated page for Inotiv news (Ticker: NOTV), a resource for investors and traders seeking the latest updates and insights on Inotiv stock.

Inotiv, Inc. (NASDAQ: NOTV) is a contract research organization focused on nonclinical and analytical drug discovery and development services and research models and related products and services. The NOTV news feed on Stock Titan brings together company-issued updates, earnings announcements, strategic collaborations, legal and regulatory disclosures, and operational developments that shape the outlook for this preclinical services provider.

Investors and industry observers following Inotiv’s news can track segment trends in its Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) businesses, including commentary on safety assessment, general toxicology, biotherapeutic analysis, discovery and translational sciences, and non-human primate (NHP) product and service revenues. Regular earnings releases and preliminary results updates provide insight into revenue mix, operating performance, backlog, and book-to-bill ratios across these segments.

Inotiv’s news flow also covers strategic initiatives such as its collaboration with VUGENE to integrate an AI-enabled bioinformatics and computational platform into its Discovery & Translational Sciences Division, and its initiative to leverage LifeNet Health’s TruVivo system to incorporate human-relevant in vitro models into its disease pharmacology offering. These items offer context on how the company is incorporating new approach methodologies and data-driven tools into early-stage research support.

Regulatory and legal developments are another key component of NOTV news. Filings and press releases have addressed matters such as settlements of securities class action and derivative litigation, updates on investigations related to non-human primate importations, and disclosures about a cybersecurity incident and related privacy class actions. Capital structure updates, including engagement of financial advisors to explore debt refinancing alternatives and activity on credit facilities, also appear in the company’s communications.

By reviewing the NOTV news page, readers can follow how Inotiv communicates its financial results, operational progress, collaborations, risk factors, and governance changes over time, all directly based on its public disclosures.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.84%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.59%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.12%
Tags
conferences earnings
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.48%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.98%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.62%
Tags
conferences
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.68%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.46%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-35.63%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.83%
Tags
conferences earnings

FAQ

What is the current stock price of Inotiv (NOTV)?

The current stock price of Inotiv (NOTV) is $0.2291 as of April 10, 2026.

What is the market cap of Inotiv (NOTV)?

The market cap of Inotiv (NOTV) is approximately 7.9M.